Development and Validation of Models to Predict Postoperative Complications for Patients With Cardiac Surgery
Launched by CHINA NATIONAL CENTER FOR CARDIOVASCULAR DISEASES · May 9, 2021
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating and testing a tool that can help doctors predict potential complications after cardiac surgery. By looking at different risk factors, the goal is to better understand which patients might face challenges after their surgery. This information can then be used to help doctors make better decisions, provide clear guidance to patients, and plan treatments more effectively.
To participate in this study, individuals must be at least 18 years old and scheduled to undergo cardiac surgery. The trial is currently recruiting participants, and it welcomes people of all genders. Those who join the study will be contributing to important research that aims to enhance patient care and safety during and after heart surgery. It's important to note that anyone with missing information related to their health outcomes may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age more than 18 years Undergoing Cardiovascular surgery
- Exclusion Criteria:
- • Missing primary outcomes or variables
About China National Center For Cardiovascular Diseases
The China National Center for Cardiovascular Diseases (NCCD) is a leading research and clinical trial sponsor dedicated to advancing cardiovascular health in China and globally. As a prominent institution, NCCD focuses on innovative research, clinical management, and education in cardiovascular medicine. The center plays a crucial role in conducting rigorous clinical trials aimed at developing new therapies and improving patient outcomes for cardiovascular diseases. Through collaboration with national and international partners, NCCD is committed to enhancing the understanding of cardiovascular conditions and translating research findings into practical applications for improved healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
Yuefu Wang, MD
Principal Investigator
China National Center for Cardiovascular Diseases
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials